Yubo International Biotech Limited (YBGJ)

OTCMKTS · Delayed Price · Currency is USD

0.0065

-0.0054 (-45.38%)

Aug 21, 2026, 4:00 PM EST

-80.06% (1Y)

Market Cap	2.03M -63.4%
Revenue (ttm)	12.35K +256.0%
Net Income	-1.06M
EPS	-0.01
Shares Out	170.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.0119
Previous Close	0.0119
Day's Range	0.0065 - 0.0119
52-Week Range	0.0065 - 0.0546
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells. The company offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. It also provides light application products, including respiratory atomization products; cell basidiomycetes compound dr... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

CEO Yang Wang

Employees 14

Stock Exchange OTCMKTS

Ticker Symbol YBGJ

Full Company Profile

Financial Performance

In 2025, YBGJ's revenue was $12,353, an increase of 255.99% compared to the previous year's $3,470. Losses were -$1.08 million, -39.21% less than in 2024.

Financial Statements